FACTS ABOUT HEMGENIX REVEALED

Range of suitable people: CDEC talked over the uncertainty in the volume of sufferers with moderately extreme to serious hemophilia B in Canada eligible for etranacogene dezaparvovec. Clinical experts consulted by CADTH indicated that some people who will be labeled as possessing moderate or reasonable condition might have a severe bleeding phenoty